Search

Search Constraints

You searched for: Author/Creator Park, Y S

Search Results

4. Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial. (20th February 2019)

6. DOP67 Comparison of the pharmacokinetics of CT-P13 between Crohn's Disease and Ulcerative Colitis in biologic-naïve patients; a prospective multi-center observational study of the KASID. (27th May 2021)

8. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients. (2nd February 2018)

9. Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study. (13th July 2018)